Veiga-Matos, J.; Morales, A.I.; Prieto, M.; Remião, F.; Silva, R.
Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels. Molecules 2023, 28, 7532.
https://doi.org/10.3390/molecules28227532
AMA Style
Veiga-Matos J, Morales AI, Prieto M, Remião F, Silva R.
Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels. Molecules. 2023; 28(22):7532.
https://doi.org/10.3390/molecules28227532
Chicago/Turabian Style
Veiga-Matos, Jéssica, Ana I. Morales, Marta Prieto, Fernando Remião, and Renata Silva.
2023. "Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels" Molecules 28, no. 22: 7532.
https://doi.org/10.3390/molecules28227532
APA Style
Veiga-Matos, J., Morales, A. I., Prieto, M., Remião, F., & Silva, R.
(2023). Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels. Molecules, 28(22), 7532.
https://doi.org/10.3390/molecules28227532
